F Zannad

10.0k total citations · 1 hit paper
20 papers, 756 citations indexed

About

F Zannad is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F Zannad has authored 20 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F Zannad's work include Cardiovascular Function and Risk Factors (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). F Zannad is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). F Zannad collaborates with scholars based in France, United States and Germany. F Zannad's co-authors include Barbara Roniker, Richard M. Bittman, James D. Neaton, Marjorie Gatlin, B. Pitt, Shauna Hurley, Jay H. Kleiman, Felipe A. Martínez, François Alla and Nelly Agrinier and has published in prestigious journals such as Circulation, European Heart Journal and International Journal of Obesity.

In The Last Decade

F Zannad

19 papers receiving 722 citations

Hit Papers

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
    2003 539 citations B. Pitt, F Zannad et al. profile →

Peers

F Zannad
Masayuki Yamaji Japan
Daniel J.P. Burns United States
Chiho Kawahara Japan
Carolyn L. Lekavich United States
Per Hildebrandt Denmark
Karpov IuA Russia
Dennis Kannenkeril Germany
Diego Albrecht Switzerland
Giuseppe Andronico Italy
Mojca Lunder Slovenia
Masayuki Yamaji Japan
F Zannad
Citations per year, relative to F Zannad F Zannad (= 1×) peers Masayuki Yamaji

Countries citing papers authored by F Zannad

Since Specialization
Citations

This map shows the geographic impact of F Zannad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Zannad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Zannad more than expected).

Fields of papers citing papers by F Zannad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Zannad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Zannad. The network helps show where F Zannad may publish in the future.

Co-authorship network of co-authors of F Zannad

This figure shows the co-authorship network connecting the top 25 collaborators of F Zannad. A scholar is included among the top collaborators of F Zannad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Zannad. F Zannad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holm, Hannes, Martin Magnusson, Amra Jujić, et al.. (2023). Ventricular–arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort. Atherosclerosis. 374. 11–20. 11 indexed citations
2.
3.
Wachter, Rolf, William T. Abraham, JoAnn Lindenfeld, et al.. (2017). P1475Positive effects of baroreflex activation therapy in heart failure with reduced ejection fraction are independent of baseline blood pressure. European Heart Journal. 38(suppl_1). 2 indexed citations
4.
Agewall, Stefan, P. Rossignol, F Zannad, et al.. (2017). P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status. European Heart Journal. 38(suppl_1). 1 indexed citations
5.
Böhm, Michael, Jan‐Christian Reil, Peter Bramlage, Bertram Pitt, & F Zannad. (2011). Clinical efficacy of aldosterone-blocking agents. European Heart Journal Supplements. 13(Suppl B). B36–B39. 3 indexed citations
6.
Rossignol, Patrick, Wafae Iraqi, Michaël Angioı̈, et al.. (2009). H016 Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the ephesus study. Archives of cardiovascular diseases. 102. S77–S77. 2 indexed citations
7.
Zannad, F, Nelly Agrinier, & François Alla. (2009). Heart failure burden and therapy. EP Europace. 11(Supplement 5). v1–v9. 75 indexed citations
8.
Zannad, F. (2007). Benefits of First-Line Combination of Perindopril and Indapamide in Clinical Practice for Patients With Hypertension and Diabetes. American Journal of Hypertension. 20(7). S9–S14. 3 indexed citations
9.
Radauceanu, Anca, Frédéric Moulin, Mathieu Djaballah, et al.. (2006). Residual Stress Ischaemia is Associated with Blood Markers of Myocardial Structural Remodelling. European Journal of Heart Failure. 9(4). 370–376. 11 indexed citations
10.
Quilliot, Didier, François Alla, P. Böhme, et al.. (2005). Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. International Journal of Obesity. 29(11). 1321–1328. 48 indexed citations
11.
Remme, W., Charles Cline, Andrew Cohen, et al.. (2003). SHAPE: A Pan-European general public heart failure awareness and survey. Circulation. 108. 693–693.
12.
13.
Fagnani, Francis, et al.. (2001). [Management, cost and mortality of a cohort of patients with advanced heart failure (the EPICAL study)].. PubMed. 56(1). 5–10. 5 indexed citations
14.
Stoltz, J.F., et al.. (1999). Influence of a calcium antagonist on blood rheology and arterial compliance in hypertension: comparison with a thiazide diuretic.. PubMed. 21(3-4). 201–8. 11 indexed citations
15.
Briançon, S., et al.. (1997). [Measurement of functional inability and quality of life in cardiac failure. Transcultural adaptation and validation of the Goldman, Minnesota and Duke questionnaires].. PubMed. 90(12). 1577–85. 29 indexed citations
16.
Carré, A, F Zannad, & D Vasmant. (1992). The French multicentre study of ramipril in ambulatory patients with mild-to-moderate hypertension.. PubMed. 9(3). 105–12. 3 indexed citations
17.
Zannad, F, et al.. (1985). [Blood hyperviscosity syndrome in essential arterial hypertension. Characterization and clinical effects].. PubMed. 78(11). 1706–9. 1 indexed citations
18.
Zannad, F, et al.. (1984). Initial results with diltiazem in limiting myocardial infarct size (MIS). Journal of Molecular and Cellular Cardiology. 16. 32–32. 1 indexed citations
19.
Zannad, F, et al.. (1983). Effects of Exercice on Platelet Function and Blood Viscosity in Ischemic Heart Disease. European Heart Journal. 4(suppl B). 5–5. 1 indexed citations
20.
Zannad, F, et al.. (1982). [Detection and quantification of left-to-right intracardiac shunts by angiocardioscintigraphy].. PubMed. 75(8). 917–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Yamaji Breakdown of academic impact, for papers by Daniel J.P. Burns Breakdown of academic impact, for papers by Chiho Kawahara Breakdown of academic impact, for papers by Carolyn L. Lekavich Breakdown of academic impact, for papers by Per Hildebrandt Breakdown of academic impact, for papers by Karpov IuA Breakdown of academic impact, for papers by Dennis Kannenkeril Breakdown of academic impact, for papers by Diego Albrecht Breakdown of academic impact, for papers by Giuseppe Andronico Breakdown of academic impact, for papers by Mojca Lunder
Rankless by CCL
2026